The University of Saskatchewan and University of Regina rivalry will take to the field for the Canada West championship this ...

Researchers say study offers proof-of-concept that targeting how T cells interact with metabolites in their environment can ...

As cancer cells grow, they pump out metabolic byproducts such as lactic acid into the tumor microenvironment. Exhausted T ...

The FDA approved obecabtagene autoleucel (obe-cel; Aucatzyl) for treating relapsed or refractory B-cell precursor acute ...

CAR-T cell therapy, a marvel of bioengineering, takes a patient’s own immune cells and reprograms them to attack cells ...

Approval of the CD19 chimeric antigen receptor T-cell therapy (CAR T) — which, according to Autolus, was specifically “designed to have a ‘fast-off’ kinetic” to minimize excessive activation of the ...

Bharti says it isn’t clear what exactly caused the vision improvements. It’s possible that the transplanted cells themselves ...

UC San Francisco treated its first brain cancer patient with an experimental new CAR-T therapy discovered and manufactured at ...

Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.

Researchers from the Josep Carreras Leukaemia Research Institute have found that the efficacy of varni-cel, a CAR-T infusion product for B-ALL patients, is highly dependent on intrinsic features of ...

“I didn’t realize it, but when I was getting my treatment ... Duong launched Swab the World in 2018 to draw attention to the ...

That suggests transplant recipients’ cells age at a similar rate to those in their donors, and they don’t have an increased ... which makes it difficult to draw broad conclusions.